SCHEMBL9320950

SCHEMBL9320950

CCCCCCCCNC(=S)NCc1ccc(OCCN)c(OC)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9320317 1.00
SCHEMBL9321064 0.94
SCHEMBL9123850 0.89 LMNA (0.56)
SCHEMBL9126082 0.89
SCHEMBL9321108 0.87 ALDH1A1 (0.57)
SCHEMBL9323157 0.87 ALDH1A1 (0.57)
SCHEMBL9323114 0.86 QPCT (0.49)
SCHEMBL9320209 0.86 EPHX2 (0.58)
SCHEMBL9321060 0.84 EPHX2 (0.52)
SCHEMBL9321069 0.84 EPHX2 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0282127-B1 Beta-aminoethyl-substituted phenyl compounds, and anti-inflammatory or analgesic compositions containing them PROCTER & GAMBLE (US) 1994-02-02 EP disclosed
US-5099030-A Phenols or phenolic ethers THE PROCTER & GAMBLE COMPANY (US) 1992-03-24 US disclosed
US-5045565-A Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain THE PROCTER & GAMBLE COMPANY (US) 1991-09-03 US disclosed